Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Novel HIV integrase inhibitors designed by Bioflexis

Jan. 5, 2006

New agents with activity against HIV reported in patent literature

Jan. 4, 2006

Samaritan initiates new phase IIb for SP-01A in HIV

Jan. 4, 2006

Further development of Tanox's novel HIV drug TNX-355 supported by recent data

Dec. 30, 2005

New HIV integrase inhibitors claimed in recent Bristol-Myers Squibb patent

Dec. 30, 2005

NDA submitted for protease inhibitor TMC-114

Dec. 29, 2005

Compounds demonstrating activity against HIV disclosed in recent patent literature

Dec. 22, 2005

New data on vicriviroc presented at ICAAC

Dec. 22, 2005

Compounds with potential in the treatment of HIV infection disclosed

Dec. 14, 2005

Canadian clearance for first-in-man study of PPL-100 for drug-resistant HIV

Dec. 13, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...